Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Cancer Surviv. 2017 Jan 13;11(3):393–400. doi: 10.1007/s11764-017-0596-1

Table 2.

Survey response rates by participant characteristics overall and by study arm

Characteristic Arm 1 Arm 2 Arm 3 Arm 4 Total p-valuea
Overall 594/991 (59.9%) 510/996 (51.2%) 519/1000 (51.9%) 379/999 (37.9%) 2002/3986 (50.2%)
Year of diagnosis 0.05
2010-2011 294/495 (59.4%) 247/498 (49.6%) 258/500 (51.6%) 171/499 (34.3%) 970/1992 (48.7%)
2012-2013 300/496 (60.5%) 263/498 (52.8%) 261/500 (52.2%) 208/500 (41.6%) 1032/1994 (51.8%)
Gender 0.52
Female 312/501 (62.3%) 265/498 (53.2%) 224/455 (49.2%) 179/477 (37.5%) 980/1931 (50.8%)
Male 282/490 (57.6%) 245/498 (49.2%) 295/545 (54.1%) 200/522 (38.3%) 1022/2055 (49.7%)
Age at diagnosis (years) 0.01
<40 10/17 (58.8%) 4/14 (28.6%) 10/19 (52.6%) 18/39 (46.2%) 42/89 (47.2%)
40-49 35/62 (56.5%) 34/66 (51.5%) 50/102 (49.0%) 38/98 (38.8%) 157/328 (47.9%)
50-59 116/207 (56.0%) 105/217 (48.4%) 112/262 (42.7%) 96/250 (38.4%) 429/936 (45.8%)
60-69 152/274 (55.5%) 147/275 (53.5%) 187/310 (60.3%) 118/298 (39.6%) 604/1157 (52.2%)
70-79 192/287 (66.9%) 123/243 (50.6%) 114/201 (56.7%) 88/222 (39.6%) 517/953 (54.2%)
80+ 89/144 (61.8%) 97/181 (53.6%) 46/106 (43.4%) 21/92 (22.8%) 253/523 (48.4%)
Race/ethnicity <0.001
Non-Hispanic White 381/561 (67.9%) 342/575 (59.5%) 364/606 (60.1%) 295/620 (47.6%) 1382/2362 (58.5%)
African-American 58/117 (49.6%) 49/102 (48.0%) 33/69 (47.8%) 12/65 (18.5%) 152/353 (43.1%)
Asian/Pacific Islander 53/103 (51.5%) 45/108 (41.7%) 54/115 (47.0%) 20/109 (18.3%) 172/435 (39.5%)
Hispanic 97/199 (48.7%) 71/200 (35.5%) 62/200 (31.0%) 50/199 (25.1%) 280/798 (35.1%)
Other/Unknown 5/11 (45.5%) 3/11 (27.3%) 6/10 (60.0%) 2/6 (33.3%) 16/38 (42.1%)
Language preference <0.001
Spanish 34/72 (47.2%) 33/83 (39.8%) 9/41 (22.0%) 10/40 (25.0%) 86/236 (36.4%)
English 542/883 (61.4%) 454/868 (52.3%) 500/935 (53.5%) 364/923 (39.4%) 1860/3609 (51.5%)
Other/Missing 18/36 (50.0%) 23/45 (51.1%) 10/24 (41.7%) 5/36 (13.9%) 56/141 (39.7%)
Socioeconomic status <0.001
Low 100/198 (50.5%) 86/193 (44.6%) 72/177 (40.7%) 46/167 (27.5%) 304/735 (41.4%)
Medium/High 403/634 (63.6%) 346/626 (55.3%) 352/637 (55.3%) 264/643 (41.1%) 1365/2540 (53.7%)
Missing 91/159 (57.2%) 78/177 (44.1%) 95/186 (51.1%) 69/189 (36.5%) 333/711 (46.8%)
Stage at diagnosis 0.02
0 60/126 (47.6%) 65/121 (53.7%) 52/123 (42.3%) 35/119 (29.4%) 212/489 (43.4%)
1 191/305 (62.6%) 177/338 (52.4%) 165/313 (52.7%) 115/310 (37.1%) 648/1266 (51.2%)
2 163/255 (63.9%) 138/272 (50.7%) 120/232 (51.7%) 97/247 (39.3%) 518/1006 (51.5%)
3 145/242 (59.9%) 112/215 (52.1%) 149/266 (56.0%) 108/265 (40.8%) 514/988 (52.0%)
4 27/46 (58.7%) 14/39 (35.9%) 25/53 (47.2%) 22/53 (41.5%) 88/191 (46.1%)
Unknown 8/17 (47.1%) 4/11 (36.4%) 8/13 (61.5%) 2/5 (40.0%) 22/46 (47.8%)
a

The p-value tests for differences in response rates in the “total” column between characteristic categories.